2020
DOI: 10.3390/md18110541
|View full text |Cite
|
Sign up to set email alerts
|

Marine-Derived Penicillium purpurogenum Reduces Tumor Size and Ameliorates Inflammation in an Erlich Mice Model

Abstract: Background: This study addresses the antitumoral properties of Penicillium purpurogenum isolated from a polluted lagoon in Northeastern Brazil. Methods: Ethyl Acetate Extracellular Extract (EAE) was used. The metabolites were studied using direct infusion mass spectrometry. The solid Ehrlich tumor model was used for antitumor activity. Female Swiss mice were divided into groups (n = 10/group) as follows: The negative control (CTL−), treated with a phosphate buffered solution; the positive control (CTL+), treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 59 publications
0
3
0
Order By: Relevance
“…Cyclophosphamide is a drug that reduces the risk of recurrence and mortality in early breast cancer [41]. Although the use of cyclophosphamide in vitro would be unfeasible, since its action depends on a primary conversion that occurs in the liver [42], it modulates inflammation and the immune response in the Ehrlich model, and is used as a reference drug in in vivo breast cancer experimental models [20,[43][44][45].…”
Section: Discussionmentioning
confidence: 99%
“…Cyclophosphamide is a drug that reduces the risk of recurrence and mortality in early breast cancer [41]. Although the use of cyclophosphamide in vitro would be unfeasible, since its action depends on a primary conversion that occurs in the liver [42], it modulates inflammation and the immune response in the Ehrlich model, and is used as a reference drug in in vivo breast cancer experimental models [20,[43][44][45].…”
Section: Discussionmentioning
confidence: 99%
“…As a result, aquatic-derived bioactive compounds have been reported to play a critical role to human health and nutrition. Notable examples include fish-derived clotting factors (Fomina et al, 2020), Seaweed antioxidants (Zerrifi et al, 2018), common water hyacinth, Eichhornia crassipes anticancer phytochemicals (Mtewa et al, 2021), anti-obesity polysaccharides from red algae (Yang et al, 2019), novel conopeptides from marine snails (Zhang et al, 2021), antiinflammatory cembranoids from soft coral (Peng et al, 2020), novel AMPs from sea weed, Porphyra yezoensis (Jiao et al, 2019), anchovy fish-derived antioxidant peptides (Najafian and Babji, 2018), Marine-derived Penicillium purpurogenum anti-tumor metabolites (Teles et al, 2020), Salmon calcitonin anti-glycemic and anti-osteoporosis peptides (Chesnut et al 2008), and fish-derived CF-14 AMPs (Li et al, 2019) among others. Despite, these tremendous contributions to drug leads, majority of the studies seem to focus much few highly valued species of marine habitats, with far limited emphasis on freshwater biochemical compounds.…”
Section: Discussionmentioning
confidence: 99%
“…Teles and collaborators [ 12 ] reported the antitumor properties of a Penicillium purpurogenum ethyl acetate extracellular extract, rich in meroterpenoids, using an Erlich mouse model. The extract decreased tumor-associated inflammation and necrosis without causing weight loss nor renal and hepatic toxicity.…”
mentioning
confidence: 99%